<DOC>
	<DOCNO>NCT01014533</DOCNO>
	<brief_summary>Insomnia sleep abnormality common , persistent , associated relapse alcohol-dependent patient . The overall , long-term objective propose research investigate neurophysiologic mechanism sleep disturbance associate relapse patient alcohol dependence , target mechanism medication order reduce relapse risk . The specific research aim : 1 . To investigate three potential mechanism sleep disturbance alcoholic patient : impaired sleep drive , impaired circadian regulation alertness , brain hyperactivation ; 2 . To investigate short-term effect medication sleep regulatory mechanism alcoholic ; 3 . To investigate short-term clinical course alcoholism function baseline sleep parameter . In Study Phases I &amp; II ( Screening &amp; Baseline : 10+ day ) , subject assess diagnose alcohol dependence , determine baseline value drink sleeping , rule confound sleep-impairing cause . Phase III ( Medication : 10 day ) , randomize , double-blind parallel design comparison gabapentin vs. placebo mechanism sleep . It therapeutic clinical trial . Phases II &amp; III 7 day monitor sleep activity , follow 3 night sleep laboratory assess all-night EEG activity Dim-Light Melatonin Onset ( DLMO ) , measure circadian rhythm . Phase IV 2-day medication taper Phase V ( Follow-up ) consist one visit 12 week assess course drinking . In summary , sleep disturbance alcoholic patient increase risk relapse . This study propose investigate mechanism cause sleep disturbance alcoholic determine mechanisms predict return drink 12 week . Relevance : Alcoholism devastate chronic disorder one year affect 10 % adult , cost $ 185 billion , cause 100,000 death U.S . Despite treatment , alcoholic patient achieve short-term abstinence . Medically-based treatment improvement need target neurophysiologic mechanisms relapse . Overall public health improve develop science-based treatment augment exist , partially effective , treatment approach .</brief_summary>
	<brief_title>Pharmacotherapy Mechanisms Sleep Disturbance Alcohol Dependence</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Meet DSMIV criterion alcohol dependence ( confirm SCID ) Between 3 12 week since last drink ( measure TLFB ) At least 2 week since last detoxification medication , relevant An alcohol withdrawal rating score &lt; 8 ( measure CIWAAr ) rule acute alcohol withdrawal effect sleep . Expresses desire stop drinking willingness abstain alcohol and/or drug abuse ( except nicotine ) Subjects meet DSMIV criterion dependence psychoactive substance alcohol ( except nicotine ) past 3 month ( per SCID interview ) . Subjects current ( past 1 month ) DSMIV diagnosis panic disorder , generalize anxiety disorder , posttraumatic stress disorder , major depression , anorexia nervosa , bulimia nervosa ( per SCID interview ) and/or require ongoing psychotropic medication . Subjects lifetime diagnosis meeting DSMIV criterion bipolar disorder , schizophrenia , schizoaffective disorder , delusional ( paranoid ) disorder , obsessivecompulsive disorder . Urine drug screen positive amphetamine , barbiturate , benzodiazepine , cocaine , marijuana , opioids . ( If positive , subject one opportunity test negative week abstinence ) . Medical disorder pain syndrome may affect sleep ; history head trauma loss consciousness ; history seizure ( except alcoholrelated seizure ) . Subjects elevate renal test ( blood urea nitrogen creatinine ) , gabapentin renally eliminate , elevate liver transaminase ( &gt; 3X normal ) , abnormal thyroid test thyroid problem affect sleep . Sleep disorder insomnia sleep apnea/hypopnea index &gt; 10 per hour periodic limb movement disorder ; PLM &gt; 15 movement per hour arousal . On medication know affect sleep ( e.g. , antidepressant , anticonvulsant , centrally act antihistamine , neuroleptic , sedativehypnotics , stimulant , centrally act antihypertensive [ alphamethyldopa , reserpine , clonidine ] , oral corticosteroid , theophylline within past 2 week 5 week fluoxetine ) . Subjects medication use treat addiction ( e.g. , disulfiram , naltrexone acamprosate ) exclude unknown effect sleep . Subjects even midnight shift work . ( Subjects travel across multiple time zone previous two week include discretion P.I . ) Pregnancy , breast feeding , inadequate contraception woman childbearing potential . Subjects unable unlikely follow study protocol investigator 's opinion , cognitive deficit ( MiniMental State Exam score &lt; 27 ) , personality disorder , serious suicide risk , dangerousness others , illiteracy , unstable distant living situation . Subjects know allergy , hypersensitivity contraindication study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Alcoholism</keyword>
	<keyword>Alcohol dependence</keyword>
	<keyword>Insomnia</keyword>
	<keyword>Dim light melatonin onset</keyword>
	<keyword>Gabapentin</keyword>
</DOC>